| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/02/2011 | US20110129935 Protein stability assay using a fluorescent reporter of protein folding |
| 06/02/2011 | US20110129922 Method for inducing differentiation into cardiomyocytes using g-csf |
| 06/02/2011 | US20110129916 Monoclonal antibodies with specificity for fetal erythroid cells |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129859 Biomarker for diagnosis of liver disease |
| 06/02/2011 | US20110129858 Prognosis Biomarker for Evaluating the Cure Level of Stroke Patient and a Method thereof |
| 06/02/2011 | US20110129852 Organic compounds |
| 06/02/2011 | US20110129848 Antibody Recognizing G Protein, and Agent and Kit Using the Same |
| 06/02/2011 | US20110129842 Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms |
| 06/02/2011 | US20110129819 Diagnosis of hereditary spastic paraplegias (hsp) by indentification of a mutation in the kiaa1840 gene or protein |
| 06/02/2011 | US20110129813 2'-branched nucleosides and flaviviridae mutation |
| 06/02/2011 | US20110129611 Decorating hydroxyapatite biomaterials with modular biologically active molecules |
| 06/02/2011 | US20110129534 Reduction of dermal scarring |
| 06/02/2011 | US20110129511 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 06/02/2011 | US20110129502 Immunogenic Constructs |
| 06/02/2011 | US20110129498 Vaccine for the prevention and therapy of hcv infections |
| 06/02/2011 | US20110129485 Modified Galectin-2 and Uses Thereof |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129477 NOGO Receptor Homologs |
| 06/02/2011 | US20110129476 Mzb1, a novel b cell factor, and uses thereof |
| 06/02/2011 | US20110129475 Basb 205 polypeptides and polynucleotides from haemophilus influenzae |
| 06/02/2011 | US20110129474 Methods And Systems For Multi-Antibody Therapies |
| 06/02/2011 | US20110129466 Methods of treating cancer by administering antibodies to cd200 |
| 06/02/2011 | US20110129465 Mammalian Receptor Proteins; Related Reagents and Methods |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129415 Novel antibody and use in diagnosis and therapy of arthropathies |
| 06/02/2011 | US20110129413 Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo |
| 06/01/2011 | EP2327985A2 T1R Hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 06/01/2011 | EP2327778A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same |
| 06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
| 06/01/2011 | EP2327763A1 Generation of antigen specific T cells |
| 06/01/2011 | EP2327724A2 Modified human growth hormone polypeptides and their uses |
| 06/01/2011 | EP2327723A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 06/01/2011 | EP2327722A2 Mammalian genes involved in viral infection and tumor suppression |
| 06/01/2011 | EP2327721A2 Genetic products which are differentially expressed in tumours and use thereof |
| 06/01/2011 | EP2327720A1 Enterococcus antigens |
| 06/01/2011 | EP2327719A1 Hybrid and tandem expression of neisserial proteins |
| 06/01/2011 | EP2327718A1 Improved expression systems with SEC-system secretion |
| 06/01/2011 | EP2327717A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327716A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327715A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327713A1 Metal-binding compounds and uses therefor |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2327709A2 Modulation of glucagon receptor expression |
| 06/01/2011 | EP2327705A1 Podophyllotoxins as antiproliferative agents |
| 06/01/2011 | EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses |
| 06/01/2011 | EP2327417A2 Identification of surface-associated antigens for tumour diagnosis and therapy |
| 06/01/2011 | EP2326725A1 Production of l-ribose and other rare sugars |
| 06/01/2011 | EP2326718A1 Inhbb epitope peptides and vaccines containing the same |
| 06/01/2011 | EP2326670A1 Hetero-multivalent binding agents for members of the tgf superfamily |
| 06/01/2011 | EP2326669A2 Pta072 protein |
| 06/01/2011 | EP2326667A1 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment |
| 06/01/2011 | EP2326666A1 Neuropeptide-2 receptor (y-2r) agonists and uses thereof |
| 06/01/2011 | EP2326665A1 Non-cytotoxic fusion proteins comprising egf muteins |
| 06/01/2011 | EP2326664A2 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 06/01/2011 | EP2326663A2 Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof |
| 06/01/2011 | EP2326661A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies. |
| 06/01/2011 | EP2326660A2 Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae |
| 06/01/2011 | EP2326659A2 Production of infectious hepatitis c virus particles in cell culture |
| 06/01/2011 | EP2326344A1 Salmonella vectored vaccines against chlamydia and methods of use |
| 06/01/2011 | EP2326333A1 Agent for promoting neuronal differentiation and method therefor |
| 06/01/2011 | EP2118668B1 Method of determining equine nt-probnp. |
| 06/01/2011 | EP2054439B1 Cd4-receptor-derived peptides and method for the preparation thereof |
| 06/01/2011 | EP1999141B1 Novel genes encoding insecticidal proteins |
| 06/01/2011 | EP1945661B1 Gpr 146 receptor |
| 06/01/2011 | EP1729569B1 Transgenic model for alzheimer's disease |
| 06/01/2011 | EP1584925B1 Novel screening method |
| 06/01/2011 | EP1485490B1 Yield-related polynucleotides and polypeptides in plants |
| 06/01/2011 | EP1354946B1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 06/01/2011 | EP1073759B1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 06/01/2011 | CN1805755B Therapeutic use of anti- CS1 antibodies |
| 06/01/2011 | CN1589403B Methods of assaying connective tissue growth factor |
| 06/01/2011 | CN1582771B Production of collagen peptide from fish skins |
| 06/01/2011 | CN102083988A Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods |
| 06/01/2011 | CN102083985A IbOrange gene involved in carotenoid accumulation from ipomoea batatas |
| 06/01/2011 | CN102083984A Cynomolgus toll-like receptor 3 |
| 06/01/2011 | CN102083979A HBV epitope reactive exogenous T cell receptor (TCR) and uses thereof |
| 06/01/2011 | CN102083974A Partial peptide of lacritin |
| 06/01/2011 | CN102083962A Method for collecting functional cells in vivo with high efficiency |
| 06/01/2011 | CN102083857A Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 06/01/2011 | CN102083856A Modified factor IX polypeptides and uses thereof |
| 06/01/2011 | CN102083855A New insulin analogues of prolonged activity |
| 06/01/2011 | CN102083854A Glycosylated GLP-1 peptide |
| 06/01/2011 | CN102083853A Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 06/01/2011 | CN102083851A Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopetidases |
| 06/01/2011 | CN102083462A Lentiviral gene transfer vectors and their medicinal applications |
| 06/01/2011 | CN102080118A Preparation method of rice bran antioxidant active protein peptide |
| 06/01/2011 | CN102080089A Gene of enhancing stress resistance such as drought resistance and the like of plant and application thereof |
| 06/01/2011 | CN102080088A Cotton dehydrin similar gene and application thereof |
| 06/01/2011 | CN102080079A Preparation method and application of novel antimicrobial peptide Misgurin mutant |
| 06/01/2011 | CN102080078A Cotton NAC transcription factor gene and application thereof |
| 06/01/2011 | CN102080061A L-glutamic acid-producing microorganism and a method for producing l-glutamic acid |
| 06/01/2011 | CN102079789A Method for detecting maduramicin and special enzyme-linked immunoassay reagent kit thereof |
| 06/01/2011 | CN102079788A Method for detecting sulfanilamide medicine and special enzyme-linked immunoassay reagent kit thereof |
| 06/01/2011 | CN102079785A Thymopoietin-II mutant |
| 06/01/2011 | CN102079784A Canine interferon-Alpha mutant |
| 06/01/2011 | CN102079783A Japanese blood fluke protein and application thereof |
| 06/01/2011 | CN102079782A Antibacterial peptide used for killing Cryptocaryon irritans and preparation method and applications thereof |
| 06/01/2011 | CN102079781A Immunogenic protein in schistosoma japonicum soluble egg antigen as well as screening method and application thereof |